DMTK Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 1.16% compare to its pairs and should correct upwards.

Stats
Today's Volume	3.40M
Average Volume	1.78M
Market Cap	3.29M
EPS	$-0.580 ( Q1 \| 2024-05-15 )
Next earnings date	( $-0.520 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0400 (Sector) 42.63 (Industry) 0
ATR14	$0.00100 (1.05%)

ACRS 4.55%

AKU -17.87%

APDN 33.45%

BDSX 0.00%

BIOC 0.00%

BNGO -2.32%

BNR -0.16%

CDNA -0.97%

CEMI 0.22%

CHEK 3.03%

CNTG 2.73%

CSTL -2.66%

DMTK -11.32%

DRIO -1.68%

EXAS 0.43%

FLDM -7.02%

FLGT 2.14%

GENE -5.37%

GH -2.15%

GTH 0.12%

HTGM 0.00%

ICLR 0.97%

IDXX -2.22%

ILMN 1.07%

ISPC -1.91%

LAB -2.26%

LMDX 0.00%

MDXH -1.26%

ME -3.83%

MEDP -1.12%

MYGN -2.00%

MYNZ -13.92%

NDRA -4.43%

NEO 0.43%

NEOG -3.77%

NOTV -4.22%

NTRA -0.44%

OCDX 0.92%

OLK 0.27%

OPGN -2.98%

OPK -1.60%

PMD -2.89%

PRPO 6.01%

PSNL 2.14%

RDNT -0.63%

SERA 2.03%

SHC -2.44%

SQL 0.00%

STIM -2.78%

STRR -3.52%

STRRP -6.57%

SYNH 0.02%

TRIB 6.28%

TTOO 0.75%

TWST -0.71%

VIVO 0.00%

XGN -0.55%

Insider Trading

Date	Person	Action	Amount	type
2024-06-10	Sun Kevin M	Sell	445	Common Stock
2024-06-05	Akhavan Ramin	Sell	1 757	Common Stock
2024-06-05	Akhavan Ramin	Sell	1 988	Common Stock
2024-06-05	Sun Kevin M	Sell	179	Common Stock
2024-06-05	Sun Kevin M	Sell	2 236	Common Stock

INSIDER POWER
70.69
Last 97 transactions
Buy: 1 342 530 \| Sell: 288 525

Correlation (AI algo v.1.1b): Undervalued: 1.16% $0.0962 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.04 (neutral)

Short: 0.51 (weak)

Signal:(53.647) Neutral

DermTech Inc Correlation

10 Most Positive Correlations
AUUD	0.955
RDUS	0.95
BMBL	0.949
AGRX	0.945
WBD	0.944
SMSI	0.944
RRGB	0.941
LPSN	0.94
NARI	0.94
ACON	0.94

10 Most Negative Correlations
NTRA	-0.955
ESTA	-0.945
DXJS	-0.944
PNTG	-0.942
ANIP	-0.939
RNA	-0.939
SHLD	-0.938
GOGL	-0.934
CRAI	-0.933
PPC	-0.931

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

DermTech Inc Correlation - Currency/Commodity

0.00
( neutral )

-0.42
( neutral )

DermTech Inc Financials

Annual	2023
Revenue:	$15.30M
Gross Profit:	$276 000 (1.80 %)
EPS:	$-3.09

FY	2023
Revenue:	$15.30M
Gross Profit:	$276 000 (1.80 %)
EPS:	$-3.09

FY	2022
Revenue:	$14.52M
Gross Profit:	$647 000 (4.46 %)
EPS:	$-3.79

FY	2021
Revenue:	$11.84M
Gross Profit:	$1.27M (10.76 %)
EPS:	$-5.42

Financial Reports:

No articles found.

DermTech Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

DermTech Inc

DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers DermTech Melanoma Test (DMT), a gene expression test that enhances early detection of genomic atypia and helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. The company also provides adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. In addition, it is developing UV damage DNA risk assessment products, as well as non-melanoma skin cancer diagnostic and cutaneous T-cell lymphoma rule out test products, as well as offering health-related and information services through electronic information and telecommunication technologies. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California.